corruption laws »
Bribery and corruption ‘on the rise’
The level of fraud, bribery and corruption has increased since the economic downturn according to 28 per cent of Irish respondents to a new survey. This compares to 16 per cent in Western Europe. Ernst
Read More »The Top 5 Corruption Risks for Pharmaceutical and Medical Device Companies
Pharmaceutical and medical device companies are fast becoming the enforcement punching bag, eclipsing the long-suffering status of the oil and gas energy. If you ignore the political and public relations challenges facing the
Read More »Massive bribery trial begins in Brazil
Brasilia - Brazil's biggest ever bribery trial began on Thursday with dozens of former officials facing vote-buying charges in a case that could tarnish the legacy of popular ex-leader Luiz Inacio Lula da Silva. In
Read More »Complying With The Foreign Corrupt Practices Act in African Transactions
U.S. companies are increasingly turning to African markets as desirable places to sell their products and services. However, as international business dealings continue to rise, so too does the risk of Foreign Corrupt
Read More »South Africa introduces aggressive new anti-corruption measures
Corruption in South Africa has reached staggering proportions. Daily newspapers are rife with reports of widespread corruption in both the public and private sectors. The arms deals scandal, coupled with prison sentences for the
Read More »Fighting Bribery and Corruption: Controlling the risk, limiting the damage
Organizations operating internationally need to be aware of bribery and corruption risks and have measures in place to curb their exposures. Laws and guidelines barring bribery of foreign officials, such as the U.S. Foreign
Read More »Pfizer DPA: New Minimum Best Practices for FCPA Compliance Programs?
Last week was wild in the Foreign Corrupt Practices Act (FCPA) and wider compliance world. In the FCPA arena, as most compliance practitioners are aware, Pfizer settled its FCPA enforcement action this week. In
Read More »Pfizer pays $60 million to settle bribery charges
Pfizer has agreed to pay the federal government $60 million to settle allegations that its employees bribed doctors and other foreign officials in Europe and Asia to win business and boost sales.
Read More »